DBHL Deep Isolation Nuclear, Inc.
Refuse Systems · OTC · SEC CIK 1918080 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-8.5%
TTM net income YoY-323.5%
TTM EPS YoY-271.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin54.9%
Operating margin-262.9%
Net margin-251.5%
FCF margin-200.4%
EBITDA margin-261.0%
Returns
ROE-62.3%
ROA-57.4%
ROIC (approx.)-966.3%
Asset turnover0.23x
Leverage & solvency
Liabilities / assets9.5%
Debt / equity0.00x
Current ratio10.46x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.79x
Accruals ratio-12.3%
Payout ratio—
Capex / revenue2.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $6.14M | $7.05M |
| Cost of revenue | $2.63M | $3.67M |
| Gross profit | $3.50M | $3.39M |
| R&D expense | $404,000 | $202,000 |
| SG&A expense | $8.75M | $4.14M |
| Operating income | -$5.77M | -$1.07M |
| Pretax income | -$5.33M | -$993,000 |
| Income tax | $1,000 | $1,000 |
| Net income | -$5.34M | -$994,000 |
| EBITDA | -$5.66M | -$956,000 |
| EPS (basic) | -0.11 | -0.02 |
| EPS (diluted) | -0.11 | -0.02 |
| Weighted avg. shares (diluted) | 48.68M | 39.84M |
| Balance sheet | ||
| Cash & equivalents | $27.43M | $2.15M |
| Receivables | $439,000 | $999,000 |
| Current assets | $28.82M | $3.34M |
| PP&E, net | $128,000 | $55,000 |
| Goodwill | $182,000 | $182,000 |
| Intangibles | $73,000 | $153,000 |
| Total assets | $29.62M | $4.13M |
| Current liabilities | $2.27M | $924,000 |
| Total liabilities | $2.43M | $1.21M |
| Shareholders' equity | $27.20M | $2.92M |
| Shares outstanding | 57.54M | 39.90M |
| Cash flow statement | ||
| Operating cash flow | -$3.93M | -$1.20M |
| Capital expenditure | $105,000 | $0 |
| Free cash flow | -$4.04M | -$1.20M |
| Investing cash flow | -$98,000 | $0 |
| Financing cash flow | $29.20M | $607,000 |
| Depreciation & amortization | $115,000 | $110,000 |
| Stock-based compensation | $473,000 | $112,000 |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.